Cargando…

Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants

Detalles Bibliográficos
Autores principales: Vanhove, Bernard, Marot, Stéphane, So, Ray T., Gaborit, Benjamin, Evanno, Gwénaëlle, Malet, Isabelle, Lafrogne, Guillaume, Mevel, Edwige, Ciron, Carine, Royer, Pierre-Joseph, Lheriteau, Elsa, Raffi, François, Bruzzone, Roberto, Mok, Chris Ka Pun, Duvaux, Odile, Marcelin, Anne-Geneviève, Calvez, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176966/
https://www.ncbi.nlm.nih.gov/pubmed/37187748
http://dx.doi.org/10.3389/fimmu.2023.1208705
_version_ 1785040529878155264
author Vanhove, Bernard
Marot, Stéphane
So, Ray T.
Gaborit, Benjamin
Evanno, Gwénaëlle
Malet, Isabelle
Lafrogne, Guillaume
Mevel, Edwige
Ciron, Carine
Royer, Pierre-Joseph
Lheriteau, Elsa
Raffi, François
Bruzzone, Roberto
Mok, Chris Ka Pun
Duvaux, Odile
Marcelin, Anne-Geneviève
Calvez, Vincent
author_facet Vanhove, Bernard
Marot, Stéphane
So, Ray T.
Gaborit, Benjamin
Evanno, Gwénaëlle
Malet, Isabelle
Lafrogne, Guillaume
Mevel, Edwige
Ciron, Carine
Royer, Pierre-Joseph
Lheriteau, Elsa
Raffi, François
Bruzzone, Roberto
Mok, Chris Ka Pun
Duvaux, Odile
Marcelin, Anne-Geneviève
Calvez, Vincent
author_sort Vanhove, Bernard
collection PubMed
description
format Online
Article
Text
id pubmed-10176966
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101769662023-05-13 Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants Vanhove, Bernard Marot, Stéphane So, Ray T. Gaborit, Benjamin Evanno, Gwénaëlle Malet, Isabelle Lafrogne, Guillaume Mevel, Edwige Ciron, Carine Royer, Pierre-Joseph Lheriteau, Elsa Raffi, François Bruzzone, Roberto Mok, Chris Ka Pun Duvaux, Odile Marcelin, Anne-Geneviève Calvez, Vincent Front Immunol Immunology Frontiers Media S.A. 2023-04-28 /pmc/articles/PMC10176966/ /pubmed/37187748 http://dx.doi.org/10.3389/fimmu.2023.1208705 Text en Copyright © 2023 Vanhove, Marot, So, Gaborit, Evanno, Malet, Lafrogne, Mevel, Ciron, Royer, Lheriteau, Raffi, Bruzzone, Mok, Duvaux, Marcelin and Calvez https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Vanhove, Bernard
Marot, Stéphane
So, Ray T.
Gaborit, Benjamin
Evanno, Gwénaëlle
Malet, Isabelle
Lafrogne, Guillaume
Mevel, Edwige
Ciron, Carine
Royer, Pierre-Joseph
Lheriteau, Elsa
Raffi, François
Bruzzone, Roberto
Mok, Chris Ka Pun
Duvaux, Odile
Marcelin, Anne-Geneviève
Calvez, Vincent
Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
title Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
title_full Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
title_fullStr Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
title_full_unstemmed Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
title_short Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
title_sort corrigendum: xav-19, a swine glyco-humanized polyclonal antibody against sars-cov-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176966/
https://www.ncbi.nlm.nih.gov/pubmed/37187748
http://dx.doi.org/10.3389/fimmu.2023.1208705
work_keys_str_mv AT vanhovebernard corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT marotstephane corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT sorayt corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT gaboritbenjamin corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT evannogwenaelle corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT maletisabelle corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT lafrogneguillaume corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT meveledwige corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT cironcarine corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT royerpierrejoseph corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT lheriteauelsa corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT raffifrancois corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT bruzzoneroberto corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT mokchriskapun corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT duvauxodile corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT marcelinannegenevieve corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants
AT calvezvincent corrigendumxav19aswineglycohumanizedpolyclonalantibodyagainstsarscov2spikereceptorbindingdomaintargetsmultipleepitopesandbroadlyneutralizesvariants